| |
| |
|
| Insider
Information: |
Huber Reid M |
| Relationship: |
Director |
| City: |
Wilmington |
| State: |
DE |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
186,522 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,841,173 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
186,522 |
|
|
| Total
Value |
$1,841,173 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Incyte Corp |
INCY |
EVP, Chief Scientific ... |
2018-07-16 |
34,571 |
|
0 |
Premium* |
|
|
Bellicum Pharmaceuticals, Inc |
BLCM |
Director |
2023-01-03 |
146,951 |
2022-01-04 |
0 |
Premium* |
|
|
Tango Therapeutics Ord Shs |
TNGX |
Director |
2023-06-06 |
5,000 |
2023-06-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TNGX |
Tango Therapeutics Ord Sh... |
Director |
– • – |
2023-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Director |
– • – |
2023-01-03 |
4/A |
OE |
$0.00 |
$0 |
D/D |
80,968 |
146,951 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Director |
– • – |
2023-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
87,196 |
153,179 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Director |
– • – |
2022-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
46,489 |
65,983 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Director |
– • – |
2022-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,494 |
19,494 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP, Chief Scientific Officer |
• – – |
2018-07-16 |
4 |
D |
$70.19 |
$31,445 |
D/D |
(448) |
34,571 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP, Chief Scientific Officer |
• – – |
2018-07-05 |
4 |
D |
$68.28 |
$19,392 |
D/D |
(284) |
35,019 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP, Chief Scientific Officer |
• – – |
2018-02-21 |
4 |
AS |
$85.55 |
$167,507 |
D/D |
(1,958) |
35,183 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP, Chief Scientific Officer |
• – – |
2018-02-20 |
4 |
D |
$86.03 |
$91,536 |
D/D |
(1,064) |
37,141 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP, Chief Scientific Officer |
• – – |
2017-12-01 |
4 |
AS |
$98.01 |
$68,215 |
D/D |
(696) |
38,205 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP, Chief Scientific Officer |
• – – |
2017-09-13 |
4 |
D |
$123.15 |
$85,220 |
D/D |
(692) |
38,862 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP, Chief Scientific Officer |
• – – |
2017-07-05 |
4 |
A |
$0.00 |
$0 |
D/D |
3,517 |
39,554 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP, Chief Scientific Officer |
• – – |
2017-05-08 |
4 |
AS |
$119.21 |
$1,022,464 |
D/D |
(8,577) |
36,037 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP, Chief Scientific Officer |
• – – |
2017-05-05 |
4 |
D |
$125.00 |
$966,500 |
D/D |
(7,732) |
44,614 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP, Chief Scientific Officer |
• – – |
2017-01-09 |
4 |
AS |
$113.55 |
$1,332,963 |
D/D |
(11,739) |
52,185 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP, Chief Scientific Officer |
• – – |
2016-11-09 |
4 |
AS |
$109.95 |
$298,514 |
D/D |
(2,715) |
63,924 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP, Chief Scientific Officer |
• – – |
2016-10-07 |
4 |
AS |
$96.40 |
$1,128,748 |
D/D |
(11,709) |
66,601 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP, Chief Scientific Officer |
• – – |
2016-10-07 |
4 |
OE |
$18.32 |
$214,509 |
D/D |
11,709 |
78,310 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP, Chief Scientific Officer |
• – – |
2016-08-02 |
4 |
AS |
$87.96 |
$879,600 |
D/D |
(10,000) |
66,601 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP, Chief Scientific Officer |
• – – |
2016-07-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,555 |
76,601 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP, Chief Scientific Officer |
• – – |
2016-02-16 |
4 |
OE |
$18.32 |
$98,507 |
D/D |
5,377 |
71,046 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP, Chief Scientific Officer |
• – – |
2016-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,610 |
65,669 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP, Chief Scientific Officer |
• – – |
2015-09-21 |
4 |
AS |
$124.29 |
$1,242,900 |
D/D |
(10,000) |
62,865 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP, Chief Scientific Officer |
• – – |
2015-09-21 |
4 |
OE |
$18.32 |
$183,200 |
D/D |
10,000 |
72,865 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP, Chief Scientific Officer |
• – – |
2015-08-07 |
4 |
OE |
$17.79 |
$150,486 |
D/D |
8,397 |
62,857 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
